Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Conditions: Primary Biliary Cholangitis Interventions: Drug: Seladelpar 10 mg; Drug: Placebo Sponsors: CymaBay Therapeutics, Inc. Recruiting

Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials